Pathological findings in a patient with alpha-synuclein p.A53T and familial Parkinson ' s disease

被引:7
作者
Nishioka, Kenya [1 ]
Hashizume, Yoshio [2 ]
Takanashi, Masashi [1 ]
Daida, Kensuke [1 ]
Li, Yuanzhe [1 ]
Yoshino, Hiroyo [3 ]
Tambasco, Nicola [4 ]
Prontera, Paolo [5 ]
Hattori, Yuko [6 ]
Ueda, Akihiro [7 ]
Watanabe, Hirohisa [7 ]
Hattori, Nobutaka [1 ]
机构
[1] Juntendo Univ, Sch Med, Dept Neurol, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan
[2] Fukushimura Hosp, Choju Med Inst, 19-14 Noyoricho, Yamanaka, Aichi 4418124, Japan
[3] Juntendo Univ, Grad Sch Med, Res Inst Dis Old Age, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan
[4] Univ Perugia, Santa Maria Misericordia Hosp, Neurol Dept, Movement Disorders Ctr, Perugia, Italy
[5] Univ Perugia, Santa Maria Misericordia Hosp, Med Genet Unit, Perugia, Italy
[6] Honmachi Neurol Clin, Naka Ku, 3-20-29 Sakae, Nagoya, Aichi 4600008, Japan
[7] Fujita Hlth Univ, Dept Neurol, 1-98 Dengakugakubo,Kutsukake Cho, Toyoake, Aichi 4701192, Japan
基金
日本学术振兴会;
关键词
Familial Parkinson's disease; Pathology; Alpha-synuclein; Genetics; BRAIN PATHOLOGY; A53T;
D O I
10.1016/j.parkreldis.2020.11.001
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The present report documents a patient harboring an alpha-synuclein p.A53T variant from a family presenting with autosomal dominant inheritance, including four patients clinically diagnosed with Parkinson's disease (PD) and two with dementia. The alpha-synuclein p.A53T variant is linked to youngor middle-aged onset parkinsonism and cognitive decline. Our patient had a different haplotype from that of a patient with a p.A53T variant from an Italian family. The proband presented at 42 years of age with progressive parkinsonism and good response to levodopa in the early stages of the disease. At 46 years of age, he developed delusions and cognitive decline. Brain magnetic resonance imaging showed bilateral atrophic changes in the hippocampus and temporal lobes. He died of pneumonia at the age of 52 years. Neuropathological examination revealed severe neuronal loss in the substantia nigra, locus coeruleus, and dorsal nucleus of the vagus nerve, as well as widespread Lewy pathology including Lewy bodies and neurites, corresponding to Braak stage 6, and diffuse neocortical-type PD. There was mild appearance of tau pathology and glial cytoplasmic inclusion, in the absence of TDP-43 pathology. Alpha-synuclein p.A53T characteristically cause the Lewy body pathology and the symptoms, that resembled those of the reported patients with p.A53T.
引用
收藏
页码:183 / 187
页数:5
相关论文
共 50 条
  • [41] alpha-Synuclein as a Biomarker for Parkinson's Disease: A Gut Feeling
    Merello, Marcelo
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2016, 3 (05): : 519 - +
  • [42] Rationale for Therapeutic Silencing of Alpha-Synuclein in Parkinson's Disease
    Maraganore, Demetrius M.
    JOURNAL OF MOVEMENT DISORDERS, 2011, 4 (01) : 1 - 7
  • [43] The Role of Astrocytes and Alpha-Synuclein in Parkinson's Disease: A Review
    Brash-Arias, David
    Garcia, Luis I.
    Perez-Estudillo, Cesar Antonio
    Rojas-Duran, Fausto
    Aranda-Abreu, Gonzalo Emiliano
    Herrera-Covarrubias, Deissy
    Chi-Castaneda, Donaji
    NEUROSCI, 2024, 5 (01): : 71 - 86
  • [44] Alpha-Synuclein Pathology and the Role of the Microbiota in Parkinson's Disease
    Fitzgerald, Emily
    Murphy, Sarah
    Martinson, Holly A.
    FRONTIERS IN NEUROSCIENCE, 2019, 13
  • [45] The Convergence of Dopamine and alpha-Synuclein: Implications for Parkinson's Disease
    Mor, Danielle E.
    Ischiropoulos, Harry
    JOURNAL OF EXPERIMENTAL NEUROSCIENCE, 2018, 12
  • [46] Alpha-synuclein in salivary gland as biomarker for Parkinson's disease
    Campo, Flaminia
    Carletti, Raffaella
    Fusconi, Massimo
    PeRicano, Clelia
    Pontieri, Francesco E.
    Di Gioia, Cira R.
    de Vincentiis, Marco
    REVIEWS IN THE NEUROSCIENCES, 2019, 30 (05) : 455 - 462
  • [47] The Role of Alpha-Synuclein Deposits in Parkinson's Disease: A Focus on the Human Retina
    Di Pippo, Mariachiara
    Fragiotta, Serena
    Di Staso, Federico
    Scuderi, Luca
    Abdolrahimzadeh, Solmaz
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (05)
  • [48] Skin alpha-synuclein deposit patterns: A predictor of Parkinson's disease subtypes
    Han, Yihang
    Wu, Di
    Wang, Yanjuan
    Xie, Jian
    Zhang, Zhijun
    EBIOMEDICINE, 2022, 80
  • [49] Challenging drug target for Parkinson's disease: Pathological complex of the chameleon TPPP/p25 and alpha-synuclein proteins
    Szenasi, Tibor
    Olah, Judit
    Szabo, Adel
    Szunyogh, Sandor
    Lang, Andras
    Perczel, Andras
    Lehotzky, Attila
    Uversky, Vladimir N.
    Ovadi, Judit
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2017, 1863 (01): : 310 - 323
  • [50] Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease
    Toenges, Lars
    Szegoe, Eva M.
    Hause, Patrizia
    Saal, Kim-Ann
    Tatenhorst, Lars
    Koch, Jan Christoph
    d'Hedouville, Zara
    Dambeck, Vivian
    Kuegler, Sebastian
    Dohm, Christoph P.
    Baehr, Mathias
    Lingor, Paul
    FRONTIERS IN AGING NEUROSCIENCE, 2014, 6